The Patent Finder

Potency Test for Vaccine Formulations

Intervet Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 61/377,485, filed Aug 27, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,802,378Potency Test for Vaccine Formulations
In force
 · High confidence
Intervet Inc.In force
High confidence
US 9,599,607Potency Test for Vaccine Formulations
In force
 · High confidence
Intervet Inc.In force
High confidence
US 10,101,310Potency Test for Vaccine Formulations
In force
 · High confidence
Intervet Inc.In force
High confidence
US 10,852,286Ready to Use Porcine Vaccine
In force
 · High confidence
Intervet Inc.In force
High confidence
US 8,546,149Potency Test for Vaccine Formulations
In force
 · High confidence
Intervet Inc.In force
High confidence
Application 16/129,144Potency Test for Vaccine Formulations
Abandoned
Abandoned Feb 4, 2020
Intervet Inc.AbandonedAbandoned Feb 4, 2020
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Intervet Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited